為加速產業升級提昇國家競爭力，生物科技產業為國家重點發展產業。本文利用1997年第一季至2006年第三季取樣期間，我國生物科技產業上市櫃廠商中，產值最大之生技製藥業及生技醫療器材業為研究對象，選取27家有專利權公司為樣本，建立長期追蹤資料以固定效果模型及隨機效果模型進行實證分析，探討研究創新指標、健保合作與企業特性等議題和生技廠商經營績效之關連性，藉此掌握研發型生物科技產業發展趨勢。實證結果發現生技製藥業與生技醫療器材業，其研發支出與公司報酬確實具有顯著正向相關。而「累積專利權許可數」對於製藥廠商績效的影響並不顯著。在與中央健保局建立合作機制後，帶動生技製藥產業經營正面影響之效果；並且公司成立年數與績效呈現非線性之變化趨勢。 To accelerate the industrial up-grading and promote national competitiveness, biotechnology industry is viewed as Taiwan’s crucial developing industry. This paper employs two cores – pharmaceutical industry and medical equipment industry as samples for they occupy the largest production value in Taiwan’s biotech industry. 27 patent-owned biotech firms are chosen and the period is spanned from the first quarter, 1997 to the third quarter, 2006. Fixed effect model and random effect model are utilized for the empirical analysis to catch the future developing trend for biotech industry in Taiwan. The results reveal that, for both pharmaceutical and medical equipment industries, R&D expenditure exhibits a significant positive correlation to the firm returns. However, the accumulating patent numbers are insignificant to pharmaceutical firms’ performance, while the cooperation with the Bureau of National Health Insurance promotes the firm profitability only in pharmacy. The impacts of firm ages on performance exhibit a non-linear shape tendency for both industries.
